Stephen Uden
Oprichter bij RALLYBIO CORPORATION
Vermogen: 1 M $ op 30-04-2024
Actieve functies van Stephen Uden
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| RALLYBIO CORPORATION | Directeur/Bestuurslid | 01-08-2023 | - |
| Algemeen Directeur | 01-08-2023 | - | |
| Oprichter | 01-01-2018 | - | |
| President | 01-01-2018 | - | |
| Operationeel Directeur | 01-01-2018 | 01-08-2023 | |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2018 | 01-08-2023 | |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Operationeel Directeur | 01-01-2018 | - |
| Oprichter | 01-01-2018 | - |
Loopbaan van Stephen Uden
Eerdere bekende functies van Stephen Uden
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Hoofd Techniek/Wetenschap/O&O | - | 14-09-2007 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Opleiding van Stephen Uden
| University of London | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Operating Officer | 2 |
| Founder | 2 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| RALLYBIO CORPORATION | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Commercial Services |
- Beurs
- Insiders
- Stephen Uden
- Ervaring
